Nov 18 |
Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
|
Nov 18 |
Ratio Enters License and Collaboration Agreement with Novartis for SSTR2-targeting Radiotherapeutic Candidate
|
Nov 15 |
FDA reviews Sanofi and Regeneron’s Dupixent label expansion for urticaria
|
Nov 15 |
Kodiak Q3 Loss Narrower Than Expected, Pipeline Development in Focus
|
Nov 15 |
Ouch: Why a Healthcare Selloff Really Hurts in Europe
|
Nov 14 |
Down -10.9% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)
|
Nov 14 |
Zacks.com featured highlights include Janus Henderson, Coastal Financial, Novartis, Apogee and InterDigital
|
Nov 13 |
Novartis (NVS) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now
|
Nov 13 |
Down -9.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Novartis (NVS)
|
Nov 13 |
5 Low-Leverage Stocks to Buy Amid the Focus on Inflation Data
|